# A Study of JZP150 in Adults With Posttraumatic Stress Disorder

> **NCT05178316** · PHASE2 · COMPLETED · sponsor: **Jazz Pharmaceuticals** · enrollment: 282 (actual)

## Conditions studied

- Post Traumatic Stress Disorder

## Interventions

- **DRUG:** JZP150
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05178316
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-29
- **Primary completion:** 2023-12-05
- **Final completion:** 2023-12-05
- **Target enrollment:** 282 (ACTUAL)
- **Last updated:** 2024-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05178316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05178316, "A Study of JZP150 in Adults With Posttraumatic Stress Disorder". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05178316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*